About us

Research and products:

Drug candidate mHAM 1102 is based on Primecell´s fifteen years experience with cell and tissue products, for example NTC Chondrograft®, which is in phase II/III clinical trial in EU, and extraordinary orthopedics outputs of University hospital Kralovske Vinohrady in Prague.

Cytokine Bioscience is a spin off Primecell´s research labs 4MEDi and NATIC, simillary as a spin off Biohealing (2018).

Primecell research of mHAM for orthopedics was granted by Technology agency of Czech republic, ID Trend1/FW01010339 in 2019.


Prof. Martin Krbec, MD, Ph.D.

Head of orthopedic clinic University hospital, Vice-chairman of Orthopedic society

Prof. Valér Džupa, MD

Vice dean School of medicine,
Charles University Prague

Serhiy Forostyak, MD, Ph.D.

Head of research

Mgr. Iveta Minaříková

Senior researcher


Eduard Rodriguez Perez, Ph.D.

Head of human amnion laboratories 4MEDi

Dipl.-Ing. Michal Zahradníček, MBA

Biomed enterpreneur venture,
4MEDI biotech accelerator